Legal & General Group plc isn’t the only dividend king I’d buy today

Harvey Jones says that Legal & General Group plc (LON: LGEN) is a long-standing favourite and picks out another insurer with premium potential.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Insurance giant Legal & General Group (LSE: LGEN) has been one of my favourite FTSE 100 stocks for years and it has more than justified my admiration. Its share price is up 92% over five years and 38% over 12 months, after shrugging off shocks such as the impact of pension freedom reforms on annuity sales.

Legal matters

Even better, L&G currently yields a juicy 5.31%, making it one of the most attractive income and growth stocks around. I would buy it yesterday, I would buy it today and I would buy it tomorrow. I see plenty of upside ahead but this isn’t the only insurance company on my shopping list.

RSA Insurance Group (LSE: RSA) has had a mixed time of it lately, and this is reflected in its stock performance. It trades just 25% higher than five years ago although it has been showing signs of greater urgency lately, rising 28% in the past 12 months. It has taken a knock today, falling around 2.25% on publication of its Q3 trading update.

Storm warning

This dip has mildly surprised me given that the report has been broadly welcomed by analysts. Its brief trading update showed an 8% increase in net written premiums to £5.077bn year-to-date, or 3% at constant exchange rates. Earnings per share (EPS) are ahead of last year but behind target.

The group’s underwriting performance was hit by the extreme Caribbean hurricane season, but sweep that aside and it is clear that underlying performance continues to improve. Premiums grew 5% in the UK, 8% in Scandinavia and 16% in Canada, with only Ireland disappointingly flat. The UK household insurance market is tough at the moment, but the group is taking action to mitigate that.

Write on

Group CEO and turnaround titan Stephen Hester said profits are ahead of the same period in 2016, although by less than targeted. We are continuing to drive business enhancements across the group, whilst taking further underwriting action in some portfolios to improve performance for 2018.”

City analysts are upbeat, predicting 8% earnings per share (EPS) growth in 2017 then another 21% in 2018. Its forecast dividend yield is 3.4% but nicely covered two times, giving scope for generous progression. By 2018, the yield is expected to hit 4.5%, making it a great dividend stock. Trading at a forecast 15 times earnings, today’s dip looks like a buying opportunity to me.

Generally speaking

RSA is a general insurance specialist and a very different beast to L&G, which has a massive investment management arm, and it presciently made the move into low-cost index trackers before ETFs ruled the world. It recently posted a 43% leap in first-half profits after tax to £952m and hiked its interim dividend 7.5% from 4p per share to 4.3p, in line with its stated policy of paying 30% of the previous year’s total dividend.

There will inevitably be bumps in the road after five consecutive years of double-digit EPS growth. Another 13% increase is forecast for 2017, but then a 2% dip in 2018. I would view any slippage as a buying opportunity although trading at a forecast 10.7 times earnings I would buy it today. 

L&G is vulnerable to a stock market downturn, RSA is vulnerable to the weather. This means they do not correlate and could therefore balance each other quite nicely.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Harvey Jones has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Man writing 'now' having crossed out 'later', 'tomorrow' and 'next week'
Investing Articles

This FTSE 100 Dividend Aristocrat is on sale now

Stephen Wright thinks Croda International’s impressive dividend record means it could be the best FTSE 100 stock to add to…

Read more »

Investing Articles

3 shares I’d buy for passive income if I was retiring early

Roland Head profiles three FTSE 350 dividend shares he’d like to buy for their passive income to support an early…

Read more »

Investing Articles

Here’s how many Aviva shares I’d need for £1,000 a year in passive income

Our writer has been buying shares of this FTSE 100 insurer, but how many would he need to aim for…

Read more »

Female Doctor In White Coat Having Meeting With Woman Patient In Office
Investing Articles

1 incredible growth stock I can’t find on the FTSE 100

The FTSE 100 offers us a lot of interesting investment opportunities, but there's not much in the way of traditional…

Read more »

Mature Caucasian woman sat at a table with coffee and laptop while making notes on paper
Investing Articles

With an £8K lump sum, I could create an annual second income worth £5,347

This Fool explains how a second income is achievable by using a lump sum, investing in stocks, and the magic…

Read more »

Investing Articles

Here’s what dividend forecasts could do for the BT share price in the next 3 years

With the BT share price down so low, the dividend looks very nice indeed. The company's debt is off-putting, though.…

Read more »

Hand of person putting wood cube block with word VALUE on wooden table
Investing Articles

28% revenue growth per year and down over 20% in price! Should I invest in this niche FTSE 250 company?

Oliver says this FTSE 250 company has done an excellent job bringing auctioning into the modern world. Will he invest…

Read more »

Investing Articles

After gaining over 200% in 12 months, what’s next for Nvidia stock?

Oliver thinks Nvidia stock could be as enduring an investment as Amazon. Even given the valuation risks, he says he…

Read more »